InDanio Bioscience is the only nuclear receptor and epigenetics targeted drug discovery company using Zebrafish-based HTS to simultaneously assess for bioavailability, specificity, tissue-selectivity and toxicity, resulting in enhanced efficiency and accuracy for drug discovery in major diseases.
CEO